ImmunXperts

Foundation date

15/05/2014

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

ImmunXperts offers a wide range of in silico and in vitro assays to companies developing new drugs. The purpose of these tests is to help our partners select the best and less risky drug candidates before further development into the clinical phases. We want to be a trusted partner for our clients by thinking and working together; acting as their mobile development team in the areas where they need us.

Upcoming events

Latest news

  • Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation

    9 hours ago

  • argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

    1 day ago

  • ExeVir Announces Michael Garrett as New Chief Executive Officer

    Tuesday November 19th 2024